Identification of platelet-activating factor acetylhydrolase II in human skin.
Platelet-activating factor acetylhydrolases are a family of specialized phospholipase A2 enzymes. They serve an anti-inflammatory function by converting the proinflammatory autocoid, PAF, into biologically inactive lyso-PAF, by the removal of the sn-2 acetyl group of this glycerophospholipid. Similarly, platelet-activating factor acetylhydrolases can also degrade oxidatively modified sn-2 polyunsaturated-fatty-acid-containing phospholipids, which are toxic to cells. Platelet-activating factor acetylhydrolase II is a recently cloned member of this family of specialized phospholipases. Consistent with a potential role of this intracellular enzyme in protecting membrane phospholipids against oxidative stress, platelet-activating factor acetylhydrolase II has been shown to translocate from cytosol to membranes in response to pro-oxidative stressors, and overexpression of this enzyme decreases the cytotoxic effects of these agents. The objective of this study was to assess whether platelet-activating factor acetylhydrolase II is involved in protecting skin against oxidative stress. Platelet-activating factor acetylhydrolase II protein was demonstrated in human skin by immunohistochemistry, with the highest levels of the enzyme found in sebaceous glands and lesser amounts in epidermal keratinocytes. Treatment of epidermal cells with t-butylhydroperoxide or ultraviolet B radiation resulted in platelet-activating factor acetylhydrolase II translocation from cytosol to membranes. To assess the role of this enzyme in epidermal function, a recombinant retroviral strategy was used to overexpress platelet-activating factor acetylhydrolase II in the human keratinocyte-derived cell line HaCaT. Overexpression of platelet-activating factor acetylhydrolase II protected HaCaT cells against apop tosis induced by oxidative stressors t-butylhydroperoxide and ultraviolet B radiation. Similar levels of apoptosis, however, were seen in both control and platelet-activating-factor-acetylhydrolase-II-over expressing HaCaT cells in response to C2 ceramide. These studies demonstrate the presence of platelet-activating factor acetylhydrolase II in a restricted pattern in human skin, and provide evidence that this specialized phospholipase is involved in protecting this organ against oxidative stress through the degradation of oxidatively modified bioactive phospholipids.
Marques
Mariangela
M
Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana 46202, U.S.A.
Pei
Yong
Y
Southall
Michael D
MD
Johnston
John M
JM
Arai
Hiroyuki
H
Aoki
Junken
J
Inoue
Takao
T
Seltmann
Holger
H
Zouboulis
Christos C
CC
Travers
Jeffrey B
JB
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D017209:Apoptosis; D001692:Biological Transport; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D006801:Humans; D010741:Phospholipases A / Q000032:analysis / Q000502:physiology*; D054467:Phospholipases A2; D010743:Phospholipids / Q000378:metabolism; D012867:Skin / Q000201:enzymology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000633:toxicity; D014466:Ultraviolet Rays; D020122:tert-Butylhydroperoxide / Q000633:toxicity
C064769:N-acetylsphingosine; D010743:Phospholipids; D020122:tert-Butylhydroperoxide; D010741:Phospholipases A; D054467:Phospholipases A2; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D013110:Sphingosine